CVRx, Inc. Cash and Restricted Cash
CVRx, Inc. (CVRX) had Cash and Restricted Cash of $64.59 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $64.59M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $72.30M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $75.71M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $85.12M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $64.59M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $72.30M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $75.71M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $85.12M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $95.03M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $102.67M 10-Q · filed 2026-05-12 |
| 2024-12-31 | $105.93M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $100.16M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $70.40M 10-Q · filed 2025-08-05 |
| 2024-03-31 | $80.11M 10-Q · filed 2025-05-09 |
| 2023-12-31 | $90.57M 10-K · filed 2026-02-13 |
| 2023-09-30 | $82.99M 10-Q · filed 2024-11-01 |
| 2023-06-30 | $90.81M 10-Q · filed 2024-08-02 |
| 2023-03-31 | $103.28M 10-Q · filed 2024-05-10 |
| 2022-12-31 | $106.19M 10-K · filed 2025-02-18 |
| 2022-09-30 | $109.98M 10-Q · filed 2023-10-31 |
| 2022-06-30 | $121.35M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $131.18M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $142.07M 10-K · filed 2024-02-09 |
| 2021-09-30 | $170.91M 10-Q · filed 2022-11-04 |
| 2021-06-30 | $47.13M 10-Q · filed 2022-08-01 |
| 2021-03-31 | $53.97M 10-Q · filed 2022-05-02 |
| 2020-12-31 | $59.11M 10-K · filed 2023-02-10 |
| 2020-09-30 | $63.30M 10-Q · filed 2021-11-08 |
| 2020-06-30 | $18.77M 10-Q · filed 2021-08-09 |
| 2019-12-31 | $25.74M 10-K · filed 2022-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |